TREATMENT FOR HEPATIC TOXICITY RESULTING FROM CHEMOTHERAPY FOR COLORECTAL CANCER WITH METASTATIC LIVER CANCER LESION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper shows the experience of the Russian X-ray Radiology Research Center in using S-ademetionine in patients receiving chemotherapy for metastatic liver cancer lesion.

Full Text

Restricted Access

About the authors

U. Stanoyevlch

Russian X-ray Radiology Research Center

Candidate of Medical Sciences Moscow

E. Grebenkin

Russian X-ray Radiology Research Center

Email: genbytu@mail.ru
Candidate of Medical Sciences Moscow

References

  1. Ларионова В.Б., Рябухина Ю.Э. Возможности лечения и профилактики печеночной токсичности у онкологических больных // Сопроводит. тер. в онкол. 2006; 2: 2-14.
  2. Anderson S., Holley H., Berland L. et al. Causes of jaundice during hepatic artery infusion chemotherapy // Radiology. 1986; 161 (2): 439-42.
  3. Blachar A., Federle M., Brancatelli G. Hepatic capsular retraction: spectrum of benign and malignant etiologies // Abdom Imaging. 2002; 27 (6): 690-9.
  4. Cayir K., Karadeniz A., Simşek N. et al. Pomegranate seed extract attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in rats // J. Med. Food. 2011; 14 (10): 1254-62.
  5. Fernandez F., Ritter J., Goodwin J. et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases // J. Am. Coll. Surg. 2005; 200 (6): 845-53.
  6. Floyd J., Mirza I., Sachs B. et al. Hepatotoxicity of chemotherapy // Semin. Oncol. 2006; 33 (1): 50-67.
  7. Huet P., Villeneuve J., Fenyves D. Drug elimination in chronic liver diseases // J. Hepatol. 1997; 2: 63-72.
  8. Ishak K., Zimmerman H. Morphologic spectrums of drug-induced liver disease // Gastroenterol. Clin. North. Am. 1995; 24: 759-86.
  9. Jain N., Singhai A. Protective role of Beta vulgaris L. leaves extract and fractions on ethanol-mediated hepatic toxicity // Acta Pol. Pharm. 2012; 69 (5): 845-50.
  10. Kacevska M., Mahns A., Sharma R. et al. Extra-Hepatic Cancer Represses Hepatic Drug Metabolism Via Interleukin (IL)-6 Signalling // Pharm. Res. 2013; 4: 142-6.
  11. Lee C., Park K., Hwang J. The pericarp extract of Prunus persica attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in mice // J. Med. Food. 2008; 11 (2): 302-6.
  12. Maria V., Victorino R. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis // Hepatology. 1997; 26: 664-9.
  13. McCullough A. Pathophysiology of nonalcoholic steatohepatitis // J. Clin. Gastroenterol. 2006; 40: 17-29.
  14. Mikalauskas S., Mikalauskiene L., Bruns H. et al. Dietary glycine protects from chemotherapy-induced hepatotoxicity // Amino Acids. 2011; 40 (4): 1139-50.
  15. Okamoto R., Maeda Y., Sasaki T. Hepatotoxicity of chemotherapy // Gan To Kagaku Ryoho. 2003; 30 (6): 772-8.
  16. Phongkitkarun S., Kobayashi S., Varavithya V. et al. Bile duct complications of hepatic arterial infusion chemotherapy evaluated by helical CT // Clin. Radiol. -2005; 60 (6): 700-9.
  17. Pratt D., Kaplan M. Evaluation of abnormal liver enzyme results in asymptomatic patients // N. Engl. J. Med. 2000: 342: 1266-71.
  18. Qayyum A., Lee G., Yeh B. et al. Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver // Clin. Imaging. 2007; 31 (1): 6-10.
  19. Richardson P., Guinan E. The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches // Br. J. Haematol. 1999; 107 (3): 485-93.
  20. Robinson P. The effects of cancer chemotherapy on liver imaging // Eur. Radiol. 2009; 19 (7): 1752-62.
  21. Rubbia-Brandt L., Audard V., Sartoretti P. et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer // Ann. Oncol. 2004; 15 (3): 460-6.
  22. Santini D., Vincenzi B., Massacesi C. et al. S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury // Anticancer. Res. 2003; 23 (6): 5173-9.
  23. Shenker S., Martin R., Hoyumpa A. Antecedent liver disease and drug toxicity // J. Hepatol. 1999; 31: 1098-105.
  24. Vincenzi B., Daniele S., Frezza A. et al. The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen // Supp. Care Cancer. 2012; 20 (1): 135-9.
  25. Vincenzi B., Santini D., Frezza A. et al. The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen // Exp. Opin. Drug Saf. 2011; 10 (3): 345-9.
  26. Yildirim N., Kandemir F., Ceribasi S. et al. Pomegranate seed extract attenuates chemotherapy-induced liver damage in an experimental model of rabbits // Cell. Mol. Biol. 2013; 2: 1842-7.
  27. Yildirim Z., Bidev D., Buyukavci M. Parenteral Glutamine Supplementation Has No Effect on Chemotherapy-induced Toxicity in Children With Non-Hodgkin Lymphoma // J. Pediatr. Hematol. Oncol. 2013; 2: 564-70.
  28. Young S., Paulson E., Washington K. et al. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis // Am. J. Roentgenol. 1994; 63 (6): 1385-8.
  29. Zarei M., Shivanandappa T. Amelioration of cyclophosphamide-induced hepatotoxicity by the root extract of Decalepis hamiltonii in mice // Food Chem. Toxicol. 2013; 7: 179-84.
  30. Zorzi D., Laurent A., Pawlik T. et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases // Br. J. Surg. 2007; 94 (3): 274-86.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies